Pneumocystis jirovecii genetic diversity in a Spanish tertiary hospital

Lidia Goterris1,2, Lana Pasic3,4,5, Mercedes Guerrero Murillo1

  • 1Microbiology Department, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.

Medical Mycology
|October 26, 2021
PubMed

Insights

A new multilocus sequence typing (MLST) scheme helps track Pneumocystis jirovecii. The study found high genetic diversity and potential links between specific sequence types (STs) and colonization versus pneumonia in Spanish patients.

Area of Science:

  • Medical Mycology
  • Molecular Epidemiology
  • Infectious Diseases

Background:

  • Pneumocystis jirovecii causes colonization or severe pneumonia in immunocompromised individuals.
  • Limited molecular data exists for P. jirovecii due to a lack of standardized typing schemes.
  • A new ISHAM consensus multilocus sequence typing (MLST) scheme offers a standardized approach.

Purpose of the Study:

  • To investigate the molecular epidemiology of P. jirovecii in Barcelona, Spain using the new ISHAM MLST scheme.
  • To identify potential outbreaks and associations between sequence types (STs) and clinical outcomes (colonization vs. pneumonia).
  • To examine DHPS gene mutations for potential sulfa drug resistance.

Main Methods:

  • Employed the new ISHAM consensus MLST scheme targeting four genes (β-TUB, mt26S, CYB, SOD).
  • Analyzed P. jirovecii isolates from 86 immunocompromised patients (50 colonized, 36 with pneumonia) between 2014-2018.
  • Investigated DHPS gene mutations for sulfa drug resistance.

Main Results:

  • Identified 32 distinct sequence types (STs) among the isolates.
  • The most prevalent STs were ST21 (18.5%), ST22 (14.8%), and ST37 (14.8%).
  • Specific STs (ST3, ST30, ST31) were exclusively found in pneumonia cases, while ST27 was linked to colonization. No DHPS mutations were detected.

Conclusions:

  • The new ISHAM MLST scheme effectively reveals high genetic diversity of P. jirovecii in Barcelona.
  • Specific STs may be associated with either colonization or pneumonia, warranting further investigation.
  • The scheme aids in understanding local epidemiology and identifying potential transmission events.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Sputum Studies II: Culture and Sensitivity01:20

Sputum Studies II: Culture and Sensitivity

Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...